Long-Term Follow-Up of Hepatitis B Surface Antibody Levels in Subjects Receiving Universal Hepatitis B Vaccination in Infancy in an Area of Hyperendemicity: Correlation between Radioimmunoassay and Enzyme Immunoassay

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Diagnostic Laboratory Immunology

• Publication date

  2005-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/CDLI.12.12.1442-1447.2005PMID 16339069PMCID PMC1317070
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan.

  2003cited by this paper
• Hepatitis B Virus Infection in Children and Adolescents in a Hyperendemic Area: 15 Years after Mass Hepatitis B Vaccination

  2001cited by this paper
• Long term immune response of universal hepatitis B vaccination in infancy: a community-based study in Taiwan.

  1999cited by this paper
• LONG‐TERM IMMUNE RESPONSE OF UNIVERSAL HEPATITIS B VACCINATION IN INFANCY: A COMMUNITY‐BASED STUDY IN TAIWAN

  1999cited by this paper
• Long‐term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen

  1999cited by this paper
• Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study.

  1997cited by this paper
• Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.

  1997cited by this paper
• Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination.

  1996cited by this paper
• Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence.

  1995cited by this paper
• Persistence of immunologic memory for twelve years in children given hepatitis B vaccine in infancy.

  1994cited by this paper
• Twelve-year follow-up study of hepatitis B immunization of Senegalese infants.

  1994cited by this paper
• Duration and efficacy of immune response to hepatitis B vaccine in high-risk Chinese adolescents.

  1993cited by this paper
• Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: Five years after a mass hepatitis B vaccination program

  1991cited by this paper
• Scheduling of revaccination against hepatitis B virus.

  1991cited by this paper
• Dosing schedule for recombinant hepatitis B vaccine.

  1991cited by this paper
• Timing of booster doses of hepatitis B vaccine.

  1990cited by this paper
• Protective efficacy of a recombinant DNA vaccine against hepatitis B in male homosexuals: results at 36 months.

  1990cited by this paper
• Timing of booster doses of hepatitis B vaccine

  1989cited by this paper
• Timing of hepatitis B revaccination in healthy adults.

  1987cited by this paper
• Hepatitis B vaccine in infants from an endemic area: Long‐term anti‐HBs persistence and revaccination

  1987cited by this paper
• The nutritional value of canned pet food.

  1986cited by this paper
• Long-term results of hepatitis B vaccination in patients on dialysis.

  1986cited by this paper
• [Hepatitis B immunization--when is a booster injection necessary?].

  1985cited by this paper
• Hepatitis B vaccination: how long does protection last?

  1984cited by this paper
• Hepatitis B vaccine in dialysis patients.

  1984cited by this paper
• Hepatitis B vaccination: how long does protection last?

  1984cited by this paper
• Passive/active immunization against hepatitis B.

  1984cited by this paper
• Incidence of hepatitis B virus infections in preschool children in Taiwan.

  1982cited by this paper
• Passive-active immunisation against hepatitis B: immunogenicity studies in adult Americans.

  1981cited by this paper
• Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff.

  1981cited by this paper
• Vertical transmission of hepatitis B antigen in Taiwan.

  1975cited by this paper

• Change in Hepatitis B Surface Antibody Titers After Chemotherapy in Patients With Hematological Malignancies

  2024cites this paper
• Evaluation of hepatitis B vaccination status and immune response among health care workers in a tertiary care hospital in western India

  2021cites this paper
• Prevention of Viral Hepatitis B and Related Complications

  2019cites this paper
• Hepatitis B Immunization Status of Health Care Personnel

  2018cites this paper
• Analytical performance of three diagnostic reagents for HBsAg on an automatic ELISA analyzer

  2018cites this paper
• Hepatitis B vaccination - immune response and persistence of protection in susceptible population

  2017cites this paper
• The Success of a Universal Hepatitis B Immunization Program as Part of Thailand’s EPI after 22 Years’ Implementation

  2016cites this paper
• High titers of anti‐HBs prevent rituximab‐related viral reactivation in resolved hepatitis B patient with non‐Hodgkin's lymphoma

  2016cites this paper
• Prevention of hepatitis B.

  2015cites this paper
• Age-specific prevalence of hepatitis B virus infection in young pregnant women, Hong Kong Special Administrative Region of China

  2014cites this paper
• Vaccine-Induced Anti-HBs Level in 5-6 Year-Old Malnourished Children

  2013cites this paper
• Determinants of Long-term Protection After Hepatitis B Vaccination in Infancy: A Meta-analysis

  2013influential citation
• Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy

  2012cites this paper
• Impact of neonatal hepatitis B vaccination programme on age-specific prevalence of hepatitis B infection in teenage mothers in Hong Kong

  2012cites this paper
• Serologia del virus de l'hepatitis B en infants recentment immigrats

  2011cites this paper
• Hepatitis B vaccination: disease and cancer prevention-a Taiwanese experience.

  2010cites this paper
• Revaccinatie tegen hepatitis B niet nodig, ook niet bij personen die door hun werk een verhoogd risico lopen

  2009cites this paper
• Decades of Universal Hepatitis B Vaccination in Taiwan : Impact and mplication for Future Strategies

  2007cites this paper
• Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.

  2007cites this paper
• Comparison of the Abbott Architect i2000 assay, the Roche Modular Analytics E170 assay, and an immunoradiometric assay for serum hepatitis B virus markers.

  2007cites this paper